A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes

Inclusion Criteria: * Men or women aged from 40 to 79 years * Patients with pre-existing T2DM * HbA1C \<9% * Written informed consent Exclusion Criteria: * unable to comply with the protocol, Likely to leave the trial before completion * having participated in an another trial 3à days before V1 * Pregnant or childbearing potential not using birth control method * Type 1 diabetic patients, T2Dm insulin therapy Patients with one of the following pathology: * with muscular disorders known or increase CK , or hepatic deficiency or transaminase increase * with symptomatic gall-bladder disease or/and renal insufficiency * with abnormal thyroid function * with proliferative retinopathy * with recent cardiovascular event, uncontrolled hypertension * with known chronic alcohol intake * with other severe pathology * with TC\>= 7.0 mmol/L and/or TG\>= 4mmol/L at V1 * Patients treated with Warfarin * Patients with specific ECG dysfunction